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Cited2 is widely expressed in the developing embryo and in extraembryonic tissues including the placenta. Gene expression can be induced by
a number of factors; most notably by the hypoxia inducible transcription factor, HIF1, under low oxygen conditions. Cited2 encodes for a
transcriptional co-factor that in vitro can act as both a positive and negative regulator of transcription. This function is due to its interaction with
CBP/p300 and appears to depend on whether Cited2 enables CBP/p300 to interact with the basic transcriptional machinery, or if its binding
prevents such an interaction from occurring. Here, we report a novel function for Cited2 in placenta formation, following gene deletion in mouse.
In the absence of Cited2 the placenta and embryo are significantly small from 12.5 and 14.5 dpc respectively, and death occurs in utero. Cited2
null placentas have fewer differentiated trophoblast cell types; specifically there is a reduction in trophoblast giant cells, spongiotrophoblasts and
glycogen cells. In addition, the fetal vasculature of the placenta is disorganised and there are fewer anastomosing capillaries. Given that Cited2 is
expressed in both trophoblasts and the fetal vasculature, the observed defects fit well with the sites of gene expression. We conclude that Cited2 is
required for normal placental development and vascularisation, and hence for embryo viability.
© 2006 Elsevier Inc. All rights reserved.Keywords: Cited2; Placenta; Mouse; Vasculature; Trophoblast; Gene targetingIntroduction
The placenta is essential for growth and development of the
embryo and, although it functions only during gestation, the
effects of poor function in utero can manifest well into adult life
(Barker, 2004). Efficient functioning of the placenta requires
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consists of distinct layers that are defined according to their
relative position within the placenta, and by their resident cell
types. The fetal layers of the placenta are proximal to the fetus
and include the labyrinthine, spongiotrophoblast (also known as
the junctional zone), and trophoblast giant cell (TGC) layers.
Each of these layers consist of trophoblasts, and the labyrinthine
layer also contains fetal endothelial cells. Proximal to the mother
is the maternal decidua, which consists of maternal endothelial
and decidual cells, and trophoblasts that have migrated in from
the fetal placenta. Trophoblast stem (TS) cells are located in
the extraembryonic ectoderm, and later, the chorionic ectoderm
(Tanaka et al., 1998; Uy et al., 2002). They are capable of
differentiating into all trophoblast cell types of the placenta,
and provide the overlying ectoplacental cone (EPC) with pro-
genitors for both spongiotrophoblasts and secondary TGC
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1978; Simmons and Cross, 2005).
Although the different layers of the placenta are already
formed by 10.5 dpc, they continue to grow and elaborate to meet
the demands of the embryo, and undergo remodelling facilitated
by the release ofmatrix metalloproteinases (Teesalu et al., 1999).
Regulating proliferation of progenitor cells and their differen-
tiation into the various trophoblast cell types are clearly crucial
for development of a normal placenta, and the balance between
these processes needs to be tightly controlled. Growth factors,
transcription factors and oxygen, influence proliferation and
differentiation of trophoblast and endothelial cells (Red-Horse
et al., 2004; Simmons and Cross, 2005). The molecular com-
plexity required to control placental development and function is
apparent, as mutation of increasing numbers of genes result in
placental insufficiency and fetal demise (Watson and Cross,
2005).
Expression of the transcriptional modulator Cited2 can be
induced by various stimuli including hypoxia, cytokines, growth
factors, lipopolysaccharide and shear flow (Bhattacharya et al.,
1999; Sun et al., 1998; Yokota et al., 2003). Cited2 expression is
also upregulated by progesterone signalling (Jeong et al., 2005),
in common with the transcription factor hypoxia inducible
factor 1α (HIF1α; Daikoku et al., 2003). HIF1α and Cited2
interact with CBP and p300, homologous proteins that have
acetyltransferase and E4 ubiquitin ligase activities (Chan and La
Thangue, 2001; Grossman et al., 2003). HIF1α requires CBP/
p300 in order to activate target gene transcription, and since
HIF1α and Cited2 bind overlapping sites on CBP/p300, it is
postulated that Cited2 acts as a negative regulator of HIF1α
activity (De Guzman et al., 2004; Freedman et al., 2003). Cited2
also appears to displace Ets1 from CBP/p300 (Yokota et al.,
2003), suggesting that Cited2 may also function to inhibit Ets1
activity. In contrast, it has been shown that Cited2 can bind
directly to DNA binding proteins in vitro (Lhx2, TFAP2,
PPARα, PPARγ), and through the recruitment of CBP/p300 acts
as a positive regulator of transcription (Bamforth et al., 2001;
Glenn and Maurer, 1999; Tien et al., 2004). Deletion of HIF1α/
Arnt, PPARγ or TFAP2γ all produce placental phenotypes
(Adelman et al., 1999, 2000; Auman et al., 2002; Barak et al.,
1999; Kozak et al., 1997; Maltepe et al., 1997). Therefore,
Cited2 has the potential to influence placental development at
many levels. In addition, loss of Cited2 results in fibroblast
senescence (Kranc et al., 2003), and overexpression of Cited2
results in oncogenic cell transformation (Sun et al., 1998). Such
responses suggest that Cited2 may function in cell growth con-
trol (Sun et al., 1998).
Cited2 is widely expressed in both embryonic and extra-
embryonic cells during early development (Dunwoodie et al.,
1998; Martinez-Barbera et al., 2002; Weninger et al., 2005).
Cited2 is essential for embryonic development; Cited2 null
embryos die during gestation with abnormal development of
numerous organs. They display a diverse array of cardiac mal-
formations, and show defects in establishment of the left–right
body axis, neural and adrenal development (Bamforth et al.,
2001, 2004; Martinez-Barbera et al., 2002; Schneider et al.,
2003; Weninger and Mohun, 2002; Weninger et al., 2005; Yin etal., 2002). Hypoxia-activated gene transcription is also appa-
rently deregulated in Cited2 null embryos (Yin et al., 2002).
We report here thatCited2 nulls also display profound defects
in placental development. Total placenta size is greatly reduced,
with the secondary TGC, spongiotrophoblasts, and trophoblasts
in the decidua affected in particular. These layers correlate with
domains of strongest Cited2 expression. Cited2 is not expressed
in TS cells, but onset of expression is coincident with diffe-
rentiation into TGC or spongiotrophoblasts in vitro. We there-
fore propose that Cited2 acts to regulate the production of TGC
and spongiotrophoblasts during placental development. Unusu-
ally, Cited2 is expressed in both the mesoderm-derived fetal
vessels that penetrate into the placenta, as well as in trophoblast
cells. Integrity of the fetal vessel walls and capillary formation
are clearly compromised in Cited2 mutant placentas, indicating
that Cited2 also plays a direct role in vascular development.
Therefore we provide evidence that Cited2 functions in several
different cell types during placental development.
Materials and methods
Mouse lines and genotyping
The Cited2-lacZmouse line (Cited2tm1Jpmb; (Martinez-Barbera et al., 2002) was
maintained on a C57BL/6:129 hybrid genetic background following four
backcrosses onto C57BL/6. Mice heterozygous for this Cited2 targeted allele
(Cited2+/−) were intercrossed to produce Cited2 wildtype (Cited2+/+), heterozygous
(Cited2+/−) and homozygous null (Cited2−/−) embryos for analysis. Mice and
embryos were genotyped by PCR using primers as described previously (Martinez-
Barbera et al., 2002). The Cited1neo mouse line (Cited1tm1Dunw; Rodriguez et al.,
2004) was maintained on a C57BL/6 genetic background. Mice and embryos were
genotyped by PCR using primers as described previously (Rodriguez et al., 2004).
All of the doublemutant embryos analysed in this paperwere produced from crosses
between Cited1+/neo/Cited2+/− females and Cited1neo/Y/Cited2+/− males. Noon of
the day of appearance of the vaginal plug is designated 0.5 days post coitum
(dpc). Mice were sacrificed by cervical dislocation.
Histological and gene expression analysis
Histology, RNA in situ hybridisation and X-gal staining were performed on
placental sections as previously described (Dunwoodie et al., 1997; Hogan et al.,
1994; Kaufman, 1992; Rodriguez et al., 2004). cDNA probe details are as
follows: Cited2 (Dunwoodie et al., 1998); Tpbp/4311 (Carney et al., 1993);
proliferin (PLF; Lee et al., 1988); mouse placental lactogen II (mPLII; Shida et
al., 1992); and Mest (peg1; Mayer et al., 2000). Alkaline phosphatase activity
was detected as previously described (Rodriguez et al., 2004).
Immunohistochemistry
Embryos dissected in phosphate buffered saline (PBS) were fixed for 1 h in
4% paraformaldehyde (PFA), dehydrated, embedded in paraffin, 4-μm sections
were cut and mounted on Superfrost Plus adhesion slides (Lomb Scientific P/L).
For histological analysis, sections were stained with hematoxylin and eosin. For
detection of alpha smooth muscle actin (αSMA), antigen retrieval was
performed by incubating sections (3 times) in boiled 10 mM citrate buffer for
5 min. Sections were incubated in 0.3% hydrogen peroxide (PBS) for 30 min,
washed, and incubated in 2% blocking reagent (Boehringer #1096176) for 1 h.
Antibody incubation was with mouse anti-human αSMA (Dako M0851) at 1:50
for 60 min, and then with biotinylated rabbit anti-mouse FAB fragments (Vector
Labs) at 1:200 for 10 min. The ABC detection system (Vector Labs) was used
with 3,3′-diaminobenzidine (DAB) as substrate. The following reagents were
also used: anti-BrdU (1: 200 dilution; Dako), anti-cleaved (active) caspase-3 (1:
400 dilution; Cell Signalling), and anti-p53 CM5 (1: 100 dilution; Novocastra
Laboratories).
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RNA in situ hybridisation was performed on cryosectioned placentas using
the 4311 probe. Digital photographs were taken of three central sections of each
placenta. NIH Image software was used to measure the area of the relevant
stained/unstained regions of each section. For each placental section, the area
was measured of the whole placenta, the labyrinthine layer, spongiotrophoblast
layer, glycogen cells, and maternal decidua layers (Table 1). Since the total size
of all Cited2 null placentas was reduced compared to control littermates, the area
of each layer was also represented as a percentage of the total placental area.
Generation of resin vascular casts and scanning electron microscopy
Casts of both the fetal and maternal blood spaces in the placenta at 14.5 dpc
were generated as described previously (Adamson et al., 2002; Rodriguez et al.,
2004). Tissue surrounding the resin casts was digested away using 20–30%
KOH in H2O. The casts were then washed thoroughly with distilled water, air-
dried, sputtered with gold and analysed with a scanning electron microscope
(Cambridge S360).
BrdU incorporation
Pregnant females at 11.5, 12.5 and 14.5 dpc were injected with BrdU
(100 μg/g body) into the peritoneum 3 h before sacrifice. Placentas were fixed in
4% PFA for 1 h, and processed for immunohistochemistry as above. The mitotic
index was calculated as the percentage of total cells with BrdU-positive nuclei.
Identification of low oxygen containing cells of the placenta
Hypoxyprobe (pimonidazole hydrochloride kit 100MAb1, Chemicon;
20 mg/ml solution in 0.9% NaCl) was injected (60 mg/kg) into the peritoneum
of a pregnant mouse at 10.5 and 14.5 dpc. After 3 h the mouse was sacrificed
(without the use of carbon dioxide), and the placentas were dissected in 10%
formalin. The placentas were fixed in 10% formalin for 2–16 h at room
temperature, incubated twice in 70% ethanol and stored. For detection of low
oxygen cells, immunostaining was performed as described (Raleigh et al., 1998)
with the following modifications. Instead of incubating in streptavidin
peroxidase, sections were incubated for 45 min at room temperature in the
ABC reagent (Vector Labs).
TS cell cultures and in situ hybridisation on cultured cells
TS cells were cultured in 6-well plates according to standard methods
(Tanaka et al., 1998). Once reasonably confluent, cultures were split 1:3 and
seeded onto glass coverslips (in 6-well plates). Cells were cultured for 2 days in
TS cell medium, then 2 days in differentiation medium (lacking FGF4 and
heparin). Coverslips were processed for in situ hybridisation by fixing the cells
in 4% PFA for 20 min, washing in PBS and digesting with proteinase K for
15 min at room temperature. After re-fixation, cells were treated with
triethanolamine/acetic anhydride for 2 × 5 min. Probe was diluted 1:250–
1:1000 in hybridisation buffer, and hybridisation was carried out overnight at
52°C. Washes were performed with an SSC series and RNA buffer (includingTable 1
Quantification of placenta size and of specific placental regions at 14.5 dpc
Genotype Area (mm2) a
Placenta Labyrinth (% placental area) b
Cited2+/+ (n = 3) 14.34 ± 0.43 7.76 ± 0.28 (54.11 ± 0.97)
Cited2+/− (n = 2) 12.74 ± 0.08* 7.52 ± 0.06 (59.03 ± 0.36)
Cited2−/− (n = 5) 9.99 ± 0.30** 5.87 ± 0.14** (58.76 ± 1.60)*
Cited2+/+ was compared with Cited2+/−, and Cited2−/− using Student's t test, * (P
a Mean ± standard error of mean.
b Represents proportion of placenta devoted to exchange.
c Glycogen cells in the decidua.RNase A treatment). Cells were blocked using NT (0.1 M Tris pH 7.5, 150 mM
NaCl, in water) buffer/ 1% milk powder/ 10% goat serum for 60 min at 37°C.
Anti-DIG FAB fragments were diluted 1:800 in NT buffer/ 1%milk powder/ 1%
goat serum overnight. Transcript localisation was detected using BCIP/NBT
(Sigma) in NT. Development of the colour reaction was closely monitored as it
was often rather fast and longer incubation caused lots of background. For
photography, coverslips were inverted onto a slide with PBS/20% glycerol
(Myriam Hemberger, unpublished).
Results
Cited2 null embryos die mid-gestation and display defects in
numerous organs
We have previously reported that embryos homozygous for a
null mutation in which the entire Cited2 protein-coding region
is replaced by lacZ are not viable. Systematic analysis of litters
from Cited2 heterozygous intercrosses indicated that in the
C57BL/6:129 genetic background, null embryos die from
14.5 dpc (Martinez-Barbera et al., 2002; Weninger et al., 2005).
As documented by ourselves and by others with independent
Cited2 targeted mutations, defects were found in numerous
organs including the heart, brain and adrenal glands (Bamforth
et al., 2001, 2004; Martinez-Barbera et al., 2002; Weninger et
al., 2005; Yin et al., 2002). Here we report additional defects
that are suggestive of poor blood circulation and vessel in-
tegrity, as well as anaemia (Fig. 1). Circulating blood in the yolk
sac was noticeably reduced in 27/88 null embryos (Figs. 1A, D,
E, H). 49/88 null embryos showed full body oedema (Fig. 1G).
Debris in the amniotic fluid was found in 5 nulls, suggesting
vessel leakage. Three umbilical vessels were found in 3 nulls,
and in another case the umbilical vein bifurcated near to the
junction with the placenta.
Importantly, we have also identified defects in placental
development in our Cited2 nulls, and demonstrate here for the
first time that the placenta is an organ that requires Cited2 func-
tion for its normal formation. Placenta size was reduced in all
Cited2 null conceptuses dissected from 12.5 dpc onwards (Figs.
1A, B, E, F). At 14.5 dpc, when most of the analyses were
performed, all Cited2 null conceptuses had small placentas. In
addition, there were defects in organ formation clearly visible at
the time of dissection in some of these placentas. For example,
the outer layer of the placenta (maternal decidua) was greatly
reduced in 30/88 nulls, and radiation of the major fetal vessels
into the placenta was abridged and highly disorganised in 14/88
Cited2 nulls (Figs. 1B, F). These clear phenotypes hinted at theSpongiotrophoblasts Glycogen cells c Decidua
3.43 ± 0.24 1.56 ± 0.08 2.99 ± 0.13
2.35 ± 0.06** 1.33 ± 0.10 2.62 ± 0.08
1.28 ± 0.12** 0.93 ± 0.06** 2.59 ± 0.13
< 0.05), ** (P < 0.0001).
Fig. 1. Cited2 null conceptuses show several clear phenotypes. Wildtype (A–B), heterozygous (C–D) and Cited2 null (E–H) conceptuses at 14.5 dpc. Reduced
placenta size (F), oedema (G), exencephaly (G) and reduced blood in the yolk sac (H) are evident in the null conceptus compared to control littermates. Scale bar:
290 μm (A and E), 190 μm (B and F), 230 μm (C and G) and 160 μm (D and H).
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structure of Cited2 nulls. Weight measurements of conceptuses
at the time of dissection, quantified the size differences between
the genotypes (Fig. 2). Placenta weight was significantly
reduced (P < 0.005–0.0001) in all nulls from 12.5 dpc by up
to 38%, and embryo weight from 14.5 dpc by up to 22%
(P < 0.05–0.001). Reduced embryo weight was observed 2 days
after the reduction in placental weight. This suggests that em-
bryo development is compromised due to poor placental for-
mation and function.
Cited2 is required for normal placental morphology
The mouse placenta by 10.5 dpc consists of three layers;
proximal to the fetus is the labyrinthine layer, which consists of
fetal blood vessels that express Mest (Mayer et al., 2000) and
maternal blood spaces that are lined by syncytiotrophoblasts and
cytotrophoblasts. Distal to this, the spongiotrophoblast layer
consists of spongiotrophoblasts and their derivatives, glycogen
cells; both these cells type express 4311 (Adamson et al., 2002;
Lescisin et al., 1988). Next, there is a layer of secondary TGC,
usually large in size, as they are polyploid (Zybina and Zybina,
1996). Various angiogenic, vasodilatory and anticoagulation
factors, including placental lactogens (mPL1, mPL2), proliferin
(PLF), and proliferin related protein (Plfr/Prp), are expressed by
particular subsets of TGC (Carney et al., 1993; Colosi et al.,
1987; Hemberger et al., 2003a,b; Linzer et al., 1985). Tro-
phoblasts migrate into locations within the maternal decidua;
those expressing the TGC marker PLF are present around andwithin the lumen of the maternal vessels (peri/endovascular tro-
phoblasts), whilst glycogen cells that express 4311, do not pre-
ferentially localise to vessels and thus are located interstitially
(Adamson et al., 2002). The peri/endovascular trophoblasts re-
place the endothelial cells of the maternal vessels; trophoblast
cells therefore directly line maternal blood spaces in the placenta.
To analyse the placenta phenotype found in Cited2 nulls in
more detail, we performed RNA in situ hybridisation using
marker genes (4311, mPL2, PLF, Mest) at 14.5 dpc, on con-
secutive sections fromCited2 null (n = 5) and wildtype placentas
(n = 3). We found that each of these genes was expressed in null
placentas, indicating that differentiated cell types and the cha-
racteristic layers of the mature placenta were formed (Fig. 3).
However, there were fewer spongiotrophoblasts, glycogen cells
and secondary TGC inCited2 null placentas, and the presence of
trophoblasts in the decidua was greatly reduced (Figs. 3A–C, E–
G, I–K, M–O). Interestingly, we find mPL2-expressing cells in
the decidua and believe that this is the first time that this
expression pattern has been reported. In addition, Mest expres-
sion indicated that the fetal blood vessels were less densely
organised in what appeared to be an expanded labyrinthine layer
(Figs. 3D, H, L, P). In order to quantify these observations, the
area of specific regions of the placenta was determined: whole
placenta, labyrinthine layer, spongiotrophoblast layer, glycogen
cells in the decidua, and the decidua (Table 1). Boundaries of the
different layers were clearly visualised using the marker 4311.
These measurements confirmed our initial observations and
showed that the proportional areas occupied by spongiotropho-
blasts and invasive glycogen cells, were greatly reduced (63%
Fig. 2. Placenta and embryo weights are reduced in Cited2 conceptuses. Cited2
heterozygous mice were intercrossed and the resulting placentas (A) and
embryos (B) weighed upon collection at various stages of gestation. Graphs
show the mean weight (and standard error of the mean) for the three genotypes:
Cited2 wildtype (diamonds), heterozygous (squares) and null (triangles). One-
way analysis of variance was used to identify differences between genotypes,
(*P ≤ 0.005; **P ≤ 0.0001).
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labyrinthine layer occupying a greater (9%, P < 0.05) propor-
tional area than normal.
Cell proliferation, apoptosis, and levels of p53 are unaffected
in Cited2 null placentas
A reduction in trophoblasts in Cited2 null placentas at
14.5 dpc may occur as a result of reduced cell proliferation and/
or increased cell death. Therefore, BrdU incorporation was
examined as a measure of DNA synthesis, and active (cleaved)
caspase 3 protein expression was assessed to evaluate the extent
of apoptosis. The level of p53 protein was also examined since
its accumulation in cells inhibits proliferation and/or induces
apoptosis (Harris and Levine, 2005). At 11.5 and 12.5 dpc, BrdU
was incorporated to different extents into TGC, spongiotropho-
blasts, glycogen cells, and trophoblasts and endothelial cells of
the labyrinthine layer. At 14.5 dpc, BrdU was incorporated into
all these cell types except for secondary TGC, as previously
described (Lotz et al., 2004). Active caspase 3 protein wasexamined at 12.5 dpc, and was only detected in a proportion of
decidual cells. p53 protein was detected at 12.5 dpc in secondary
TGC, spongiotrophoblasts, glycogen cells, and trophoblasts and
endothelial cells of the labyrinthine layer, as previously des-
cribed (Ren et al., 2005). The proportion of cells expressing
these proteins in particular placental cell types was determined.
There was no correlation between genotype and the detection of
BrdU, active caspase 3, or p53 (data not shown).
Cited2 is expressed in extraembryonic tissues throughout
gestation, and is found in both mesoderm-derived and
trophoblast cells of the placenta
We have previously shown, by RNA in situ hybridisation,
that Cited2 is expressed in extraembryonic endoderm and
mesoderm, and particularly in the blood islands of the visceral
yolk sac (Dunwoodie et al., 1998). We extended this expression
analysis, taking advantage of the fact that expression of the
reporter gene lacZ is under control of the endogenous Cited2
promoter in the Cited2-lacZ mice. Cited2-lacZ expression was
compared between Cited2 heterozygous (one copy of lacZ), and
null (two copies of lacZ) individuals. Cited2-lacZ expression
varied in level but not the distribution between the two geno-
types, thus Cited2-lacZ expression in Cited2 nulls is shown
(Figs. 4 and 5). Cited2-lacZ expression was observed at 7.0 dpc
in a central core of the future placental tissue, the EPC (Figs. 4A,
B). Although low levels of Cited2-lacZ expression were seen
throughout most of the embryo and extraembryonic tissues,
stronger staining was clear in the posterior nascent mesoderm
(Figs. 4A, B) and in the developing blood islands (Fig. 4B). By
the 9-somite stage (8.5 dpc), two domains of Cited2-lacZ
staining were visible in the forming placental region (Fig. 4C).
These domains of expression were in two distinct cell types. The
upper expression domain was in trophoblast cells of the EPC.
The lower expression domain was in mesoderm cells of the
allantois, and interestingly Cited2-lacZ expression was partic-
ularly strong in the allantoic mesoderm in contact with the
trophoblasts of the chorion (see alsoDunwoodie et al., 1998). No
staining was apparent at all in the trophoblasts of the chorion,
which lay between the EPC and allantoic mesoderm (Fig. 4C). A
continuation of this expression pattern was observed at 9.5 dpc
(Fig. 4E), and in addition expression was readily detected in
TGC (Figs. 4D, F). In the yolk sac, Cited2-lacZ expression was
observed in the mesodermal layer. Although expression was
strongly localised to the vessel walls in flatmount preparations, it
was difficult to identify expression in endothelial cells lining the
vessels upon sectioning (Figs. 4G, H). At 14.5 dpc, Cited2-lacZ
expressing cells were found in all trophoblast-derived layers of
the mature placenta, but were absent from maternally derived
tissue (Fig. 5A). Strong Cited2-lacZ expression was observed in
the TGC layer, and in cells directly lining the maternal blood
spaces as they traversed the spongiotrophoblast and labyrinthine
layers (Figs. 5B, E). This aspect of the expression pattern closely
resembled that of PLF (Fig. 3C). Cited2-lacZ expression was
also particularly strong in spongiotrophoblast cells (Figs. 5A, B).
In addition, Cited2-lacZ was expressed in glycogen cells, and
expression was maintained as they migrated into the decidua
Fig. 3. Spongiotrophoblast and TGC layers in particular are reduced inCited2 nulls at 14.5 dpc. Transverse sections of Cited2wildtype (A–H) and null (I–P) placentas.
4311 marks spongiotrophoblasts and glycogen cells. mPL2 and PLF label subsets of secondary TGC. The greatly reduced number of invasive glycogen cells, mPL2-
and PLF-expressing cells in decidua of null placentas is marked with an asterisk. Mest marks the endothelial cells of the fetal blood vessels in the labyrinthine layer.
Small panels to the right of each placental section are magnifications of the boxed areas. Scale bar: 130 μm (A–D and I–L) and 410 μm (E–H and M–P).
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related with patterns of 4311 andmPL2 expression (Figs. 3A, B).
In the labyrinth, Cited2-lacZ was expressed in trophoblast cells,
and in the endothelial and smooth muscle cells of the fetal ves-
sels (Figs. 5B, E). However, expression was strikingly absent
from the columnar epithelium at the base of the labyrinthine
layer, the chorionic plate (Figs. 5F, G). Patterns of staining for
Cited2-lacZ in the fetal vessels (allantois-derived) and for alka-
line phosphatase in the chorionic trophoblasts were mutually
exclusive in this region (compare Figs. 5G and H). The Cited2-
lacZ expression presented in Fig. 5 was generated from the
Cited2 null conceptuses as two copies of lacZmade detection of
expression more robust than one copy present in Cited2 hetero-
zygotes. The Cited2-lacZ expression domains were the same in
Cited2 heterozygous and null placentas, however as previously
described there are fewer TGC, spongiotrophoblasts and tro-
phoblast derivatives in the decidua.
In summary, Cited2-lacZ was expressed in placental tissue
throughout gestation. Cited2-lacZ staining was seen in most
differentiated trophoblast cell types; with the regions of
strongest expression correlating with the layers most affected
in the Cited2 nulls. Staining was also seen in the extraembryonic
mesoderm that forms the fetal vessels. It is relatively unusual for
a gene to be expressed in both mesoderm-derived and tropho-blast compartments of the placenta (Simmons and Cross, 2005).
Interestingly, Cited2-lacZ was not expressed in the chorionic
trophoblasts that interact with the allantoic mesoderm. The
chorion layer undergoes buckling and invagination to allow the
fetal vessels to penetrate the labyrinth, and also contains TS cells.
Cited2 is expressed in differentiating trophoblast cells in
culture
TS cells can be grown in culture, and maintained in a pro-
liferative state if given the appropriate growth factors (Guzman-
Ayala et al., 2004; Tanaka et al., 1998). TS cells can also be
induced to differentiate into various trophoblast cell types, and
express markers characteristic of these cell types. Since Cited2
was strongly expressed in the placenta, we addressed whether it
was also expressed in cultured trophoblast cells (Fig. 6). In
particular, we examined whether Cited2 was expressed in pro-
liferating TS cells, or in differentiating trophoblasts. We found
that Cited2 was strongly expressed in differentiating trophoblast
cells, in a pattern similar to 4311 andmPL1/2 expression (Fig. 6).
However, expression of Cited2 in the colonies of small, tightly
packed TS cells was negligible (Fig. 6A). Therefore, we con-
clude that Cited2 is expressed in TGC and spongiotrophoblasts,
but largely absent from TS cells, both in vivo and in vitro.
Fig. 4. Cited2-lacZ is expressed in placental tissues from early stages. Lateral
views and sagittal section of embryos, anterior to the left (A–C). (A) Full length
streak stage. (B) Late headfold stage. (C) 9-somite stage (8.5 dpc), allantois
(arrow). (D) Inner lining of the decidua at 9.5 dpc, TGC (arrow). (E, F) Sagittal
sections of 9.5 dpc placenta, EPC-derived trophoblasts (arrow in panel E), TGC
(arrow in F). (G) Flatmount view of a yolk sac from a 14.5 dpc. H: Transverse
section of 15.5 dpc yolk sac. Cited2 null (A–F,H), Cited2 heterozygous (G).
EPC (*), chorion (c), allantoic mesoderm (a). Scale bar: 275 μm (A), 375 μm
(B), 170 μm (C), 1.1 mm (D), 400 μm (E, F), 180 μm (G, H).
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allantois
The labyrinth is named because of the intricate structure of
convoluted and interconnecting maternal and fetal blood spaces
within this part of the placenta. Formation of the labyrinth is
initiated by interaction of two formerly spatially separate
tissues: the allantois and the chorion. The allantois is extra-
embryonic mesoderm that extends from the posterior of the
embryo to contact the trophoblast cells of the chorionic plate
(see Gardner, 1983). Interaction of the chorion and allantois
causes buckling and invagination of the chorion; this enables
the fetal endothelial cells, and later blood vessels, to penetrate
and form the labyrinth (see Downs, 2002; Cross et al., 2003).
The endothelial and smooth muscle cells of the fetal vessels in
the labyrinth are therefore derived from allantoic mesoderm.
At 10.5 dpc the labyrinth was proportionally smaller in
Cited2 nulls (data not shown), suggesting early defects in for-
mation of this layer. Cited2-lacZ was expressed particularly
strongly in the allantoic mesoderm cells that interact with the
chorion at 8.5 dpc (Fig. 4C), and expression was maintained in
the walls of fetal vessels throughout the labyrinth (Figs. 5B, F,
G).We therefore examinedwhether any defects in the interaction
between the chorion and allantois were evident in Cited2 null
placentas. Sections showed that buckling of the chorionic plate
at 9.5 dpc was noticeably reduced in Cited2 nulls (Figs. 7A, B).
Concomitantly, penetration of fetal vessels into the early pla-
centa was reduced, with the vessels remaining at the base of theplacenta. These results therefore demonstrate that interaction of
the chorion and allantois is compromised in the absence of
Cited2. However, since placentas of Cited2 nulls continued to
develop, and the labyrinth expanded to occupy a large fraction of
the 14.5 dpc placenta (Table 1), it appears that this early defect
represents a delay in vessel penetration that was overcome.
Since Cited2-lacZ was expressed in the walls of the fetal
vessels throughout the labyrinth, we examined whether the
integrity of these vessels was compromised in nulls. Such de-
fects could account for the reduced ability of the vessels to
penetrate through their environment. In wildtype placentas at
11.5 dpc, smooth muscle actin (SMA) strongly stained multiple
densely packed layers of the large fetal vessels at the base of the
labyrinth (Fig. 7D). SMA expression followed the fetal vessels
as they branched and penetrated into the labyrinth, right up to the
border with the spongiotrophoblast layer (Fig. 7E). Expression
associated with smaller fetal vessels was also seen scattered
fairly evenly throughout the labyrinth (Fig. 7F). No staining was
seen associated with maternal blood spaces in the labyrinth,
consistent with the fact that maternal blood directly contacts
trophoblast cells, with no intervening endothelial or smooth
muscle cells. In Cited2 null placentas, the density of cells that
express SMA in the wall of the large fetal vessels was clearly
reduced, and these cells were less well organised (Fig. 7G). The
density of SMA positive cells was also greatly reduced in the
walls of the vessels as they traversed the labyrinth (Fig. 7H).
Finally, the overall number of scattered clumps of SMA staining
was reduced throughout the labyrinth, indicating reduced den-
sity of fetal vessels (Fig. 7I). Nevertheless, staining was ob-
served in all regions of the labyrinth, signifying that the fetal
vessels were still able to traverse the entire layer, and reach close
to the spongiotrophoblast border.
Cited2 is required for normal organisation of the fetal
capillaries in the labyrinth
Since the labyrinth is the site of gaseous and nutrient ex-
change between the mother and fetus, the arrangement of fetal
blood vessels and maternal blood sinusoids within the labyrinth
is of fundamental importance. Altered SMA localisation (Fig.
7), together with initial observations at the time of dissection,
suggested that fetal vasculature was abnormal in Cited2 null
placentas. We extended this analysis, and gained a much clearer
understanding of the fetal and maternal circulations in three
dimensions by generating vascular casts using resin infiltration.
Casts of the fetal vasculature were generated by injection of
resin into the umbilical artery (blue) and vein (red) at 14.5 dpc
(Fig. 8). As previously described (Adamson et al., 2002;
Rodriguez et al., 2004), these casts showed that in wildtype
placentas the arterioles branched and traversed through the
entire labyrinth to the spongiotrophoblast layer, before forming
a dense mass of capillaries that extended back towards the base
of the placenta. The venuole branches, however, only penetrated
a short distance into the labyrinth and immediately formed a
mass of capillaries that extended up to meet those derived from
the arterioles (Figs. 8A, B). The fetal vasculature of manyCited2
null placentas was so impaired that resin injection was not
Fig. 5. Cited2-lacZ is expressed in both mesoderm-derived and trophoblast cells of the placenta. Transverse cryosections of 14.5 dpc Cited2 null placentas, (maternal
decidua to the top) counterstainedwith fast red (A–F are of same specimenandG–Hare of a littermate). (A)Whole placenta. (B)Maternal central canal (cc), traversing the
TGC, spongiotrophoblast and labyrinthine layers. (C) Proximal decidua (boxed in panelA), showing interstitialmigration of glycogen cells. (D)Adjacent view to panelC
(boxed in panel A), showing more distal decidua. (E) Magnified view of a maternal central canal (cc), lined by trophoblast cells, in the labyrinth. (F) Large fetal vessels
(arrows) at the base of the labyrinth. (G, H) Consecutive sections at the base of the labyrinth showingCited2-lacZ (G) and alkaline phosphatase expressing trophoblasts
(H). Maternal decidua (dec), spongiotrophoblast and TGC layer (SpTGC), labyrinthine layer (lab). Scale bar: 750 μm (A), 375 μm (B, G, H) and 190 μm (C–F).
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20 of the less affected Cited2 null placentas. In these casts, the
branching pattern and size of the large arterioles and venuoles
appeared relatively unaffected (Figs. 8C, E). However, the
overall arrangement of the vessels was generally disorganised,
as seen when the casts were cut in half and viewed side on (Figs.
8D, F). Notice also that in one of the Cited2 null placentas
shown, the umbilical vein was bifurcated, with two vessels
leaving the placenta (Fig. 8D). The most dramatic difference we
foundwas in the capillaries formed at the tips of the venuoles and
arterioles. There was variability in the severity of this phenotype,
but in 12/20 casts, the capillaries were severely stunted, dis-
organised and irregular in shape and thickness. Capillaries with
very different diameters could be seen emerging from the same
vessel. Furthermore, capillary distribution was not uniform
within each null placenta, with some parts of the labyrinth more
affected than others. In the most severe cases, almost no capil-
laries formed at all. This loss of capillaries was clearly evident by
viewing with light microscopy at low magnification, but was
vividly illustrated using scanning electron microscopy (compare
Figs. 8G, H with I–L).
Maternal vascular casts were generated following resin in-
fusion from the arterial (n = 30; Fig. 9) or venous (n = 8; data not
shown) side. A lateral view of the vascular cast filled from the
arterial side shows the arrangement of maternal arteries and
trophoblast-lined blood spaces of the placenta (Figs. 9A, B).
The organisation of the radial arteries, spiral arteries and centralcanals was similar to that previously described (Adamson et al.,
2002; Rodriguez et al., 2004) and appeared to be the same
regardless of the genotype. In wildtype placental casts viewed
from the base, the canal branches and anastomosing sinuses
radiated out to form an even circular disc. However, in 5/8 casts
from null placentas and 3/11 casts from Cited2 heterozygous
placentas, the overall diameter of the disc was slightly smaller,
with the rim disrupted and uneven (data not shown). The
sinusoids in placentas of all genotypes were well branched and
fairly regular in size (n = 30). However, the sinusoids were
slightly larger in 5/8 casts from null placentas and 2/11 casts
from Cited2 heterozygous placentas, compared to their
littermates (Figs. 9C, F). Thus, casts generated from Cited2
null placentas showed more subtle defects in the maternal blood
spaces compared to the fetal vasculature.
The distribution of cells low in oxygen is not altered in Cited2
null placentas
Expression of Cited2 is induced under conditions of low
cellular oxygen directly through HIF1α activity (Bhattacharya
et al., 1999). We therefore examined whether Cited2 expression
correlated with regions of low oxygen in the placenta. Little is
known about oxygen levels in mouse placental cell types in vivo.
We have identified that TGC, spongiotrophoblasts, and gly-
cogen cells in the decidua have low levels of oxygen (≤2%; Fig.
10). Cells in the labyrinthine layer, and those that surround the
Fig. 6. Cited2 expression in cultured trophoblast cells correlates with the in vivo
expression pattern. Light micrographs showing clusters of wildtype trophoblast
cells in culture. Cells have been fixed and processed for in situ hybridisation with
Cited2 (A, B), mPL1 (C), PLF (D) and 4311 (E, F). TS cells are present as tight
colonies of small cells (best examples are in panelsA,E; TS)whereas differentiated
trophoblast are large and rounded (present in all panels; arrows). Scale bar: 75 μm.
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Cited2 null placentas, we observed a reduction in the number of
cells that contain≤2% oxygen. However, this is likely to be due
to the fact that the cells that contain low levels of oxygen (≤2%;
TGC, spongiotrophoblasts and glycogen cells) are those that are
reduced in Cited2 null placentas. There were no other discern-
able differences in the distribution of low oxygen containing
cells between genotypes at 9.5 (data not shown) and 14.5 dpc.
Cited1 genotype does not influence the placental phenotype of
Cited2 null mice
We have previously reported that mice deficient for another
member of the Cited gene family, Cited1, also die of placental
defects (Rodriguez et al., 2004). Cited1 is expressed in TGC,
spongiotrophoblasts, and a subset of labyrinthine trophoblasts.
Cited1 null mice die immediately after birth and show intra-
uterine growth restriction. Resin casts generated of Cited1 null
placentas at 16.5 dpc showed very little difference in fetal vas-
culature but grossly enlarged maternal sinusoids (Rodriguez et
al., 2004). Given that both genes are expressed in trophoblasts, it
is possible that Cited1 function in trophoblasts may be able
to partially compensate for the lack of Cited2. To test this
hypothesis, we generated mice lacking both Cited1 and Cited2.
Mice were intercrossed to produce a range of genotypes, and
embryos and placentas were analysed at 14.5 dpc (Table 2). Thenumber of Cited2 null embryos recovered was significantly less
than expected according to Mendelian ratios, and embryo loss at
this stage did not correlate at all with Cited1 genotype (data not
shown). In each case, embryo and placenta weight was less in
Cited2−/− compared toCited2+/+ except in the case ofCited1−/−.
In males null for Cited1 (Cited1−/Y) there was no impact on the
Cited2 phenotype when compared with Cited1 wildtype males
(Cited1+/Y). Likewise in females null for Cited1 (Cited1−/−) there
was no impact on the Cited2 phenotype when compared with
Cited1 wildtype females (Cited1+/+). Taken together, these
findings show that loss of Cited1 had no obvious effect on the
severity of phenotype observed in Cited2 nulls, and suggest that
these two genes act independently.
Discussion
Here, we describe a novel role for Cited2 in the development
of the placenta. In the absence of Cited2 in the mouse, placentas
are small, have fewer TGC, spongiotrophoblasts, glycogen cells
and PLF-expressing cells in the decidua, and reduced fetal
vascular development. Cited2 is expressed in fetal endothelial
cells, TGC, spongiotrophoblasts, invasive glycogen cells, but
not in TS cells. We and others have also described a requirement
forCited2 in cardiovascular development (Bamforth et al., 2001,
2004; Martinez-Barbera et al., 2002; Weninger et al., 2005; Yin
et al., 2002). Since Cited2 is expressed in both the developing
heart and placenta, it is likely that many of the defects that occur
in these organs are a direct result of the loss ofCited2 expression.
However, placental insufficiency may have an effect on heart
development, or indeed abnormal heart development may im-
pact on placental development. Several mouse mutants with
defects in the placenta also exhibit an abnormal heart phenotype.
For some of these, the embryonic heart defects are secondary to
placental failure, since they are prevented by the provision of
wildtype trophoblasts in tetraploid chimeras (Adams et al., 2000;
Barak et al., 1999; Ihle, 2000). Supply of a wildtype placenta has
also been sufficient to rescue defects in other organs, for example
many aspects of the Rb phenotype, including in the nervous
system and haematopoiesis, are rescued in this way (de Bruin et
al., 2003; Wu et al., 2003). Tetraploid aggregation experiments
(Rossant and Cross, 2001) or conditional removal of Cited2
from the heart or placenta using Cre-LoxP technology should
establish if the loss of Cited2 in the placenta affects heart
development, and vice versa.
Formation of TGC, spongiotrophoblasts and glycogen cells
Cited2 null placentas have fewer TGC, spongiotropho-
blasts, and invasive glycogen cells, and PLF-expressing cells
in the decidua. This could occur if too few progenitor cells
differentiate to form these specific trophoblast cell types. TS
cells reside within the extraembryonic ectoderm, and later its
derivative the chorion (Tanaka et al., 1998; Uy et al., 2002).
They provide the ectoplacental cone (EPC) with progenitors
that give rise to TGC and spongiotrophoblasts (Carney et al.,
1993; Johnson and Rossant, 1981; Rossant et al., 1978). TS
cells can be derived from blastocysts or 6.5 dpc
Fig. 7. Early interaction of chorion and allantois is affected in Cited2 null placentas. (A, B) Haematoxylin and eosin staining of sections from Cited2 heterozygous (A)
and null (B) placentas at 9.5 dpc. Views show interaction of the chorion (c) and allantoic mesoderm (a), at the base of the developing labyrinth. (C) Cited2-lacZ
expression in a Cited2 null placentas at 9.5 dpc placenta. (D–I) Immunostaining for smooth muscle actin in Cited2 wildtype (D–F) and null (G–I) placentas at
11.5 dpc. Views show large fetal vessels at the base of the labyrinth (D, G) or smaller vessels throughout the labyrinth (E, H, F, I). White dots show the degree to which
the chorion has buckled. Scale bar: 120 μm (A–C), 660 μm (D–I).
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if provided with appropriate growth factors usually provided
by the adjacent epiblast (Guzman-Ayala et al., 2004; Tanaka
et al., 1998). TS cells in culture can also be induced to
differentiate and can form various trophoblast subtypes
(Hughes et al., 2004; Maltepe et al., 2005; Tanaka et al.,
1998). Since Cited2 is not expressed in TS cells in vitro, nor in
vivo in the extraembryonic ectoderm or chorion, it is more likely
that it functions in cells derived from TS cells. Gene expression
studies indicate that both TGC and spongiotrophoblasts form
from an EPC progenitor that expresses 4311. However, added
complexity appears to exist concerning trophoblast differenti-
ation, as lineage-tracing studies show that not all TGC are
derived from this common progenitor (see Watson and Cross,
2005). Mouse mutants often show disproportionate differenti-
ation biased towards TGC or spongiotrophoblasts (Guillemot et
al., 1994; Plum et al., 2001; Shi et al., 2004; Tamai et al., 2000).
Furthermore, different oxygen levels in cultures of TS cells can
promote differentiation into either TGC or spongiotrophoblasts,
and thereby regulate the fate of the trophoblast progenitors; this
response is lost in TS cells derived fromHif1βmutants (Adelman
et al., 2000). In contrast, mutations in Rap250 (Antonson et al.,
2003) or Hsf1 (Xiao et al., 1999) cause a loss in only spongio-
trophoblast cells, without affecting the TGC population, suggest-
ing that they act further downstream in the spongiotrophoblast
commitment pathway. Finally, p185/Cul7 mutants cause a de-
crease in both cell types (Arai et al., 2003) and a hypomorphicallele of Nodal causes an increase in both cell types (Ma et al.,
2001), suggesting that these two genes may act earlier in the
pathway to affect the total number of EPC progenitors formed.
Cited2 null placentas have reduced spongiotrophoblasts, second-
ary TGC, invasive glycogen cells, andPLF-expressing cells in the
decidua. This suggests that trophoblast proliferation is reduced
and/or that apoptosis is increased. We examined both these fea-
tures between 11.5 and 14.5 dpc, and found no consistent diffe-
rence between placentas of differentCited2 genotype. Therefore it
is possible that there is reduced production of TGC and
spongiotrophoblasts from their progenitor cells in the EPC.
Since evidence suggests that Cited2may function in the EPC
to generate spongiotrophoblasts and TGC, we established EPC
explant cultures; there were no detectable differences in cell
survival or differentiation between Cited2 genotypes. It is pos-
sible that an EPC phenotype might be detected in the absence of
Cited2 only when the explants are cultured under physiologi-
cally relevant low oxygen conditions, since Cited2 is associated
with hypoxic signalling.
Functional consequences of reduced trophoblasts in Cited2
null placentas
The female physiology undergoes major adaptive changes
during gestation; the TGC are central to this through the pro-
duction of luteotrophic, lactogenic, vasoactive, and anticoagu-
lative factors (Cross et al., 2002; Linzer and Fisher, 1999). TGC
Fig. 8. Fetal capillary formation is severely affected in the labyrinth of Cited2 null placentas. (A–F) Light micrographs of resin casts generated from Cited2
heterozygous (A, B) and null (C–F) placentas viewed from the base (A, C, E) and side (B, D, F). Fetal vasculature in the labyrinth was filled by injection into the
umbilical artery (blue) and vein (red) at 14.5 dpc. (G–L) Scanning electron micrographs of the same casts, showing the capillaries that form at the tips of the arterioles.
Scale bar: 1.4 mm (A, C, E), 1.3 mm (B, D, F), 290 μm (G, I), 50 μm (H, J, L) and 200 μm (K).
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displace the endothelial cells of the spiral arteries that supply the
placenta with maternal blood (Adamson et al., 2002; Hemberger
et al., 2003a). Given that Cited2 null placentas exhibit a re-
duction in both TGC and PLF-expressing endovascular invasive
TGC, one might have predicted that a consequence of this might
be disruption of the maternal blood spaces. This was not the
case; a modest increase in the size of maternal sinusoids in the
labyrinthine layer was observed. This reduction in surface area
would lead to less efficient exchange between the fetal and
maternal blood; however, the observed expansion of the laby-
rinthine layer may have gone someway towards ameliorating
this.
The function of the spongiotrophoblast layer is poorly un-
derstood. However, its compact structure suggests that it could
act as support for the developing villous structures of the
labyrinth (Cross et al., 2002; Iwatsuki et al., 2000). In addition,
cross-talk clearly exists between the spongiotrophoblast and
cells of the labyrinthine layers. Ipl and Esx1 are expressed only
in the labyrinth layer and not the spongiotrophoblasts, but their
deletion results in an expanded spongiotrophoblast layer (Frank
et al., 2002; Li, 1998). Spongiotrophoblasts also express anti-angiogenic factors such as soluble Flt1 (He et al., 1999) and
proliferin-related protein (Prp; Jackson et al., 1994; Linzer and
Nathans, 1985), which are specific antagonists of VEGF and
proliferin, respectively.
Glycogen cells are derived from the spongiotrophoblast
layer. They migrate into the decidua after 12.5 dpc but remain
interstitial, and can sometimes travel much further distances
than endovascular TGC invasion (Adamson et al., 2002).
Glycogen cells become the main source of IGF-II within the
placenta in the second half of gestation (Redline et al., 1993)
and actually require IGF-II for their differentiation (Lopez et
al., 1996). Igf2 mutant embryos show intrauterine growth
restriction, as well as reduced placental size (DeChiara et al.,
1991; Lopez et al., 1996). Importantly, deletion of just the
placenta-specific transcript of Igf2 (P0) also causes fetal
growth restriction, illustrating the importance of glucose
transport and glycogen metabolism by the placenta for
sustaining growth of the embryo during later stages of
gestation (Sibley et al., 2004). It has also been proposed that
glycogen cells have a protective role, allowing maternally and
fetally derived cells to co-exist in the placenta (Zybina, 1988).
Numerous mutants show a disruption in glycogen cell number,
Fig. 9. Cited2 null placentas show no major defects in maternal blood spaces. Resin casts of maternal blood spaces generated from Cited2wildtype (A–C) and null (D–
F) placentas, filled from the arterial side at 14.5 dpc. Light micrographs (A, D) and scanning electron micrographs (B, E) show lateral views of the whole casts.
Scanning electron micrographs at high power show the sinusoids (C, F). Maternal spiral arteries (sa), central canal (arrow), labyrinthine layer (lab). Scale bar:
1 mm (A, D), 1.25 mm (B, E) and 25 μm (C, F).
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spongiotrophoblast layer itself (Frank et al., 2002; Li and
Behringer, 1998; Yang et al., 2003). Effects on both
spongiotrophoblasts and TGC number are also evident in
cloned mouse conceptuses (Tanaka et al., 2001). However, Igf2
nulls show a loss in glycogen cells without prior reduction in
spongiotrophoblasts, whereas p57kip2 mutants have an
increased spongiotrophoblast layer but no change in glycogen
or TGC numbers (Takahashi et al., 2000). Since the number of
spongiotrophoblast cells formed in Cited2 nulls is clearly
reduced, it is no surprise that the number of glycogen cells is
also reduced. However, Cited2 may also affect differentiation
of the glycogen cells themselves, since any glycogen cells that
did form, remained close to the spongiotrophoblast layer and
were apparently unable to migrate into the maternal decidua.
Cited2 and the labyrinth
Co-ordinated infiltration of maternal and fetal blood circula-
tions into the trophoblast scaffold in the labyrinth ensures
maximal exchange of oxygen, nutrients and waste between the
mother and fetus. The labyrinthine layer contains numeroustrophoblast cell types, many of which can be identified based on
their morphology and location with respect to maternal and fetal
blood spaces (Cross, 2000). Cells lining the maternal blood
spaces are mononuclear and mPL2 positive. Adjacent to this are
two layers of syncytiotrophoblasts, and then a layer of fetal
endothelial cells (Cross, 2000).
Initial formation of the labyrinthine layer is an active process,
requiring participation of both chorionic trophoblast and
allantoic mesoderm. Following interaction of these two initially
spatially separate tissues, the chorion folds and buckles to form
villi, creating space into which the fetal blood vessels grow from
the allantois (Cross et al., 2003;Watson and Cross, 2005).Cited2
is strongly expressed in the allantoicmesoderm cells that directly
contact the chorion, but not in the chorion itself. Cited2 mutant
placentas show defects in these early interaction events, since the
chorion is relatively flat and unfolded. However, these early
defects are apparently overcome, and the labyrinth layer con-
tinues to develop into a more elaborate structure even in the
absence of Cited2. The size, number and arrangement of blood
spaces in the mature labyrinth are a consequence of the extent of
trophoblast branching (Watson and Cross, 2005). Phenotypes
described as vascular defects may therefore often be secondary
Fig. 10. A comparison of cells containing low levels of oxygen in Cited2 wildetype and null placentas. Transverse sections of Cited2 wildtype (A–C) and null (E–G)
placentas at 14.5 dpc stained for cells with low (≤2%) oxygen content. (D, H) represent secondary antibody only controls of sections adjacent to panels A and E
respectively. Boxed areas in panels A and E magnified in panels B, C , F and G. Scale bar: 1 mm (A, D), 180 μm (B, C, E, F).
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proliferation of labyrinth trophoblast cells (Wu et al., 2003). The
expression pattern of Cited2 is relatively unusual in that it is
expressed in both trophoblast cells and in mesoderm-derived
cells of the fetal vessels that penetrate the placenta. The defects
in fetal vessel integrity and in formation of fetal capillaries
observed in Cited2 null placentas might therefore be a primary
effect of loss of Cited2 expression. We will be able to directly
address this using a conditional null allele ofCited2 that we have
generated but not yet characterised.
Does the Cited2 null phenotype relate to its putative role in
hypoxic signalling?
Many cellular events that lead to development and
remodelling of the growing placenta are triggered by oxygen.
Oxygen content is a key signal, capable of influencing
differentiation of trophoblast cells into particular mature cell
types, and of inducing proliferation of endothelial cells
(Adelman et al., 2000; Damert et al., 1997; Levy et al., 2000;Schaffer et al., 2003). Furthermore, deletion of key compo-
nents of the cellular responses to hypoxia result in defects in
placental development (Adelman et al., 1999, 2000; Kozak et
al., 1997; Maltepe et al., 1997). HIF1β mutant placentas have
an underdeveloped labyrinthine layer, and a disproportionate
number of spongiotrophoblasts and TGC (Adelman et al.,
2000). In vitro studies show that hypoxia normally biases
differentiation of TS cells into spongiotrophoblasts instead of
TGC, but TS cells derived from HIF1β mutants fail to show
this increase in spongiotrophoblast differentiation in response
to hypoxia (Adelman et al., 2000; Tanaka et al., 1998). It
therefore seems likely that an aberrant response to cellular
hypoxia alters cell fate in HIF1β mutant placentas, with
severe impacts on placental development. It is unclear which
HIF1-responsive gene(s) are required to direct trophoblast cell
fate under conditions of cellular hypoxia, or how this is
achieved at the molecular level. Moreover, hypoxia-indepen-
dent roles for HIF heterodimers in the regulation of
trophoblast differentiation have also recently been identified
(Maltepe et al., 2005). We show here that null mutants for
Table 2
The phenotype of Cited1/Cited2 compound nulls is remarkably similar to that of
Cited2 nulls at 14.5 dpc
Genotype Weight (g) a
Embryo Placenta Ratio b
Cited1+/Y;
Cited2+/+ (n = 8) 0.265 ± 0.011 0.111 ± 0.004 2.384 ± 0.096
Cited2+/− (n = 14) 0.236 ± 0.009* 0.106 ± 0.003 2.230 ± 0.095
Cited2−/− (n = 10) 0.221 ± 0.011* 0.076 ± 0.002* 2.924 ± 0.151*
Cited1+/−;
Cited2+/+ (n = 10) 0.236 ± 0.015 0.111 ± 0.006 2.161 ± 0.147
Cited2+/− (n = 13) 0.225 ± 0.008 0.099 ± 0.006* 2.321 ± 0.087
Cited2−/− (n = 6) 0.200 ± 0.030* 0.063 ± 0.003* 3.169 ± 0.084*
Cited1−/Y;
Cited2+/+ (n = 10) 0.240 ± 0.008 0.110 ± 0.005 2.203 ± 0.040
Cited2+/− (n = 11) 0.244 ± 0.011 0.099 ± 0.003 2.482 ± 0.136
Cited2−/− (n = 2) 0.185 ± 0.026* 0.066 ± 0.002* 2.781 ± 0.316*
Cited1−/−;
Cited2+/+ (n = 6) 0.216 ± 0.008 0.087 ± 0.007# 2.541 ± 0.166
Cited2 +/− (n = 25) 0.223 ± 0.006 0.091 ± 0.003 2.463 ± 0.061
Cited2−/− (n = 4) 0.216 ± 0.021 0.064 ± 0.003* 3.342 ± 0.253*
Within each Cited1 genotype (+/Y, +/−, −/Y, −/−) comparisons were made
between individuals with different Cited2 genotypes (+/+, +/−, −/−), using
Student's t test, * (P < 0.05). Between each Cited1 genotype (+/Y, +/−, −/Y, −/−)
comparisons were made within individual Cited2 genotypes (+/+, +/−, −/−), no
statistical differences were observed.
a Mean ± standard error of the mean.
b Embryo/placenta ratio.
80 S.L. Withington et al. / Developmental Biology 294 (2006) 67–82Cited2, a HIF1-responsive gene, develop placental defects
similar to HIF1β mutant placentas, although less severe.
Placentas were examined for the location and prevalence of
hypoxic cells. Placentas lacking Cited2 contained fewer
hypoxic cells but this may have been due to the reduction in
spongiotrophoblasts, TGC, and glycogen cells which are the
cell types that we identified as having low oxygen levels. The
best way of ascertaining if Cited2 affects trophoblast
differentiation through a role in the hypoxic response will be
to examine trophoblast differentiation in the absence of Cited2
under, physiologically relevant, low oxygen conditions.
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